1. Home
  2. PRTC vs CVGW Comparison

PRTC vs CVGW Comparison

Compare PRTC & CVGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PureTech Health plc

PRTC

PureTech Health plc

HOLD

Current Price

$17.65

Market Cap

464.3M

Sector

Health Care

ML Signal

HOLD

Logo Calavo Growers Inc.

CVGW

Calavo Growers Inc.

HOLD

Current Price

$26.75

Market Cap

466.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRTC
CVGW
Founded
2015
1924
Country
US
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Foods
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
464.3M
466.0M
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
PRTC
CVGW
Price
$17.65
$26.75
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$33.50
AVG Volume (30 Days)
2.0K
486.0K
Earning Date
01-01-0001
04-30-2026
Dividend Yield
N/A
3.01%
EPS Growth
N/A
1950.00
EPS
N/A
1.11
Revenue
N/A
$648,434,000.00
Revenue This Year
N/A
$3.49
Revenue Next Year
N/A
$11.23
P/E Ratio
$8.09
$23.99
Revenue Growth
N/A
N/A
52 Week Low
$13.30
$18.40
52 Week High
$20.00
$28.72

Technical Indicators

Market Signals
Indicator
PRTC
CVGW
Relative Strength Index (RSI) 46.90 74.32
Support Level $17.46 $24.92
Resistance Level $18.00 $26.28
Average True Range (ATR) 0.43 0.55
MACD -0.18 0.02
Stochastic Oscillator 16.83 97.56

Price Performance

Historical Comparison
PRTC
CVGW

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

About CVGW Calavo Growers Inc.

Calavo Growers Inc is engaged in the sourcing, packing, and distribution of fresh avocados, tomatoes, and papayas, and the processing of guacamole and other avocado products. The company delivers products to retail grocers, club and mass-merchandise stores, foodservice operators, and wholesalers, sourcing avocados from California, Mexico, and other key growing regions. Its operations include sorting, packing, ripening, and shipping fresh produce, and processing and packaging fresh and frozen guacamole. The company operates through two segments: Fresh, including avocados, tomatoes, papayas, and other fresh produce products, and Prepared, including guacamole and avocado pulp, with the majority of revenue generated from the Fresh segment and geographically from the United States.

Share on Social Networks: